Rare diseases
Investigational molecules
Locations
Study of etentamig and iberdomide treatment for patients with relapsed or refractory multiple myeloma
FranceStudy of dostarlimab treatment before surgery in patients with stage II-III endometrial cancer with specific genetic markers
SpainStudy of belumosudil in children aged 1 to 18 years with moderate to severe chronic graft versus host disease requiring systemic treatment
BelgiumStudy of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
BulgariaStudy of drug combination therapy in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma using odronextamab, loncastuximab tesirine and rituximab
AustriaStudy of tarlatamab and temozolomide combination treatment in adolescents and adults with high grade brain tumors
FranceStudy of drug combination therapy after surgery in patients with resectable pancreatic ductal adenocarcinoma using lab-grown mini-tumors to guide treatment selection
GermanyStudy comparing tadalafil with ambrisentan versus tadalafil alone in newly diagnosed patients with pulmonary arterial hypertension who have cardiovascular conditions
FranceStudy of loncastuximab tesirine and epcoritamab combination treatment for patients with relapsed or refractory diffuse large B-cell lymphoma
GermanyStudy of faricimab treatment to improve vision in patients with diabetic macular edema using adaptive optics imaging
GermanyStudy of encorafenib and cetuximab treatment for patients with BRAF V600E-mutant metastatic colorectal cancer who previously responded to BRAF inhibitor therapy
SpainStudy comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
